Google+ Facebook Twitter Twitter

Influenza A(H1N2)V

Claire Atkinson, a Lecturer in Biomedical Science at London South Bank University, on the recent detection of influenza A(H1N2).

Pig Silhouetted at Twilight - stock photo-CREDIT-getty-583642526

In November 2023 the UK notified the World Health Organization (WHO) of a human case of swine-origin influenza A(H1N2)v clade 1B.1.1 virus infection. The infection was detected as part of the routine national flu surveillance undertaken by the UK Health Security Agency (UKHSA) and the Royal College of General Practitioners (RCGP) and was the first case of human influenza A(H1N2) infection detected in the UK. The case was an otherwise well person, over 75 years of age, who has since fully recovered. What makes the case intriguing is that the case reported no direct contact with pigs, pets or farms; however, pig farms are located within a few miles of where the case resides. As of December 2023, no virological confirmed transmission was reported and the source of the infection is still under investigation.

Click here to read the full article.

Image credit | Getty | Science Photo Library | iStock

Related Articles

Doctor's hands vaccinating a woman stock photo CREDIT-iStock-1444188743

A universal vaccine?

Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies and the immunocompromised.

Two Scientist Microscope images and video- istock-1363238207

Enzymes open new path to universal donor blood

The quest to develop universal donor blood has taken a decisive step forward, it is claimed.

Pseudomonas aeruginosa bacteria - CREDIT - Science-Photolibrary-f0280202

New five-year plan to combat antimicrobial resistance

The government’s national action plan will commit the UK to reducing its use of antimicrobials – such as antibiotics, antifungals and antivirals – in humans and animals, strengthen surveillance of drug-resistant infections before they emerge and incentivise industry to develop the next generation of treatments.


Sponsored: Time is of the essence in the management of sepsis

Every year, 49 million people acquire sepsis. Time is of the essence for appropriate therapy as the key driver of clinical outcomes.